Samsung C&T Q2 2020 earnings
Samsung C&T’s efforts to improve profitability in addition to performance gains at subsidiary BioLogics have led to an increase in quarter-over-quarter (QoQ) operating profit, despite a drop in year-over-year (YoY) revenue due to COVID-19 and completion of large-scale projects, etc. KRW 7.223tn in revenue and KRW 238bn in operating profit, QoQ decrease in revenue by …